C07D 263/50
Benzene-sulfonamido oxazoles
C07D263/50 (Benzene-sulfonamido oxazoles) appears on 22 US grants and 25 published applications in this corpus.
Search patents in C07D- Granted patents
- 22
- Published applications
- 25
- Assignees
- 27
- Inventors
- 105
- Latest grant
- 16 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 4 | 2 |
| 2013 | 2 | 2 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 3 | 3 |
| 2019 | 3 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Benzenesulfonamide compouds and their use as therapeutic agents16 Nov 2021US 11,174,268 B2Xenon Pharmaceuticals Inc.
- Sulfonamides as GPR40- and GPR120-agonists17 Dec 2019US 10,508,090 B2Dompé Farmaceutici S.P.A.
- Sulfonylaminobenzamide compounds as anthelmintics5 Nov 2019US 10,464,889 B2Elanco Tiergesundheit AG
- Sulfonamide compounds and uses as TNAP inhibitors6 Aug 2019US 10,370,333 B2Sanford Burnham Prebys Medical Discovery Institute
- Sulfonylaminobenzamide compounds as anthelmintics14 Aug 2018US 10,047,040 B2Elanco Tiergesundheit AG
- Modulators of cystic fibrosis transmembrane conductance regulator23 Nov 2023US 2023/0373939 A1Vertex Pharmaceuticals Incorporated
- Compounds containing a sulfonic group as kat inhibitors25 Aug 2022US 2022/0267260 A1Epizyme, Inc.
- Benzenesulfonamide compounds and their use as therapeutic agents10 Jun 2021US 2021/0171537 A1Xenon Pharmaceuticals Inc.
- Sulfonamides as gpr40- and gpr120-agonists6 Jun 2019US 2019/0169142 A1Dompé Farmaceutici S.P.A.
- Sulfonamide compounds and uses as tnap inhibitors10 Jan 2019US 2019/0010126 A1Sanford-Burnham Medical Research Institute
Most cited
By later US patents
- Sulfonamide derivatives34US 8,153,814 B2Icagen, Inc. · 2012
- Compositions useful as inhibitors of voltage-gated sodium channels14US 7,615,563 B22009
- 2-hydroxy-5-(arylazo)-benzene alkanoic acids8US 4,628,083 APharmacia Corporation · 1986
- Compositions useful as inhibitors of voltage-gated sodium channels8US 8,309,543 B2Vertex Pharmaceuticals Incorporated · 2012
- Compositions useful as inhibitors of voltage-gated sodium channels5US 8,153,655 B2Vertex Pharmaceuticals Incorporated · 2012